Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT02107833 | Study to Evaluate the Safety and Pharmacokinetics of Oral OPRX-106 (TNFR-Fc Fusion Protein) in Healthy Volunteers | PHASE1 | COMPLETED | 18 | — | — | Jul 1, 2014 | Dec 1, 2014 | Aug 4, 2015 | - | — |
| Name | Type | Description |
|---|---|---|
| OPRX-106 | DRUG | - |